Titan Pharmaceuticals Inc (TTNP)

[melody432]

Just to add my thoughts to what EMA1 posted, it's easy to get frustrated with the SP and management. But I always have to back up to what happened in April 2013 to remind myself how we got here. Titan had spent what they could spend at that point and along with virtually everyone who followed the company believed it would be approved. The FDA changed the rules in the middle of the game. I still believe this third trial was unnecessary, and I think the results compared to the prior 2 trials bears that out. The FDA could have delayed the ruling to work out the REMS and labeling issues with virtually no difference in the outcome, other than an approval in late 2013, early 2014. That didn't happen and here we are over 3 1/2 years later.
But I still believe this platform has the potential to improve lives. The biggest benefit wasn't measured by the trials, which is the ability of a recovering addict to feel like a normal human being. To be able to get treatment without being reminded your in treatment every day is a huge psychological benefit. Granted the other benefits, I think this is the one that will ultimately drive Probuphine's succcess, provided Braeburn can get enough sold to start that snowball rolling. Fingers crossed.
I've enjoyed reading this board over the past 3+ years, promise not to clutter it up.